|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
12/17/2018 |
$23.96 |
$23.98 |
$23.95 |
$23.96 |
3.91M | 12/18/2018 |
$23.96 |
$23.99 |
$23.96 |
$23.97 |
2.75M | 12/19/2018 |
$23.99 |
$24.00 |
$23.97 |
$24.00 |
2.26M | 12/20/2018 |
$23.99 |
$24.00 |
$23.99 |
$23.99 |
2.34M | 12/21/2018 |
$23.99 |
$23.99 |
$23.99 |
$23.99 |
0 |
|
Endocyte is a biopharmaceutical company developing targeted therapies for the treatment of cancer. Co. uses drug conjugation technology to create therapeutics and companion imaging agents for personalized targeted therapies. Co.'s agents target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (PSMA) in prostate cancer. Co. has rights to develop and commercialize PSMA-617 agents, including the drug candidate known as 177Lu-PSMA-617, a radioligand therapeutic. Co. is also developing a therapeutic approach that involves the re-targeting of potent immune cells, called chimeric antigen receptor T-cells to fight cancer. | |
|
ECYT (ECYT) has the following price history information. Looking back at ECYT historical stock prices for the last five trading days, on December 17, 2018, ECYT opened at $23.96, traded as high as $23.98 and as low as $23.95, and closed at $23.96. Trading volume was a total of 3.91M shares. On December 18, 2018, ECYT opened at $23.96, traded as high as $23.99 and as low as $23.96, and closed at $23.97. Trading volume was a total of 2.75M shares. On December 19, 2018, ECYT opened at $23.99, traded as high as $24.00 and as low as $23.97, and closed at $24.00. Trading volume was a total of 2.26M shares. On December 20, 2018, ECYT opened at $23.99, traded as high as $24.00 and as low as $23.99, and closed at $23.99. Trading volume was a total of 2.34M shares. On December 21, 2018, ECYT opened at $23.99, traded as high as $23.99 and as low as $23.99, and closed at $23.99. Trading volume was a total of 0 shares.
ECYT Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into ECYT shares, starting with a $10,000 purchase of ECYT, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/01/2014 |
|
End date: |
12/21/2018 |
|
Start price/share: |
$23.42 |
|
End price/share: |
$23.99 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
2.43% |
|
Average Annual Total Return: |
0.51% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$10,243.33 |
|
Years: |
4.73 |
|
|
|
Date |
Close |
12/17/2018 | $23.96 | 12/18/2018 | $23.97 | 12/19/2018 | $24.00 | 12/20/2018 | $23.99 | 12/21/2018 | $23.99 |
|
|